Showing 1 - 10 of 1,905
Persistent link: https://www.econbiz.de/10008584548
Historical accounts suggest that Jewish ?migr?s from Nazi Germany revolutionized US science. To analyze the ?migr?s' effects on chemical innovation in the United States, we compare changes in patenting by US inventors in research fields of ?migr?s with fields of other German chemists. Patenting...
Persistent link: https://www.econbiz.de/10010949130
Research on intellectual property has focused on formal legally recorded rights that we call deeded, most often measured by granted patents. Meanwhile, other "defacto" IP (mainly purposive secrecy and natural excludability) has become more important because of the increasing closeness of...
Persistent link: https://www.econbiz.de/10010950753
This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002, and information on the duration and content of patent and price control...
Persistent link: https://www.econbiz.de/10010950846
This Handbook chapter surveys the extensive body of research on the economics of the pharmaceutical industry (with peripheral attention paid also to regulated medical devices). Pharmaceuticals is one of the world's most research-intensive industries, generating a continuing steam of new products...
Persistent link: https://www.econbiz.de/10014024180
We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach regulatory approval, they are...
Persistent link: https://www.econbiz.de/10014287391
This contribution aims at analyzing the role of patents in inter-organization networks in the field of biotechnology. We examine the traditional rationale for firms to apply for a patent, which focuses on the protection against competition as the basic motive of application, and we claim that...
Persistent link: https://www.econbiz.de/10008531673
This paper quantifies the relationship between market size and innovation in the pharmaceutical industry. We estimate the elasticity of innovation, as measured by the number of new chemical entities appearing on the market for a given disease class, to the potential market size represented by...
Persistent link: https://www.econbiz.de/10009003149
We analyze how contractibility affects contract design. A major concern when designing research agreements is that researchers use their funding to subsidize other projects. We show that, when research activities are not contractible, an option contract is optimal. The financing firm obtains the...
Persistent link: https://www.econbiz.de/10008622184
This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002, and information on the duration and content of patent and price control...
Persistent link: https://www.econbiz.de/10011084584